WILMINGTON, N.C., June 12 /PRNewswire-FirstCall/ --
aaiPharma Inc. (Nasdaq: AAII) announced today that Dr. Philip S. Tabbiner,
President and Chief Executive Officer of aaiPharma, will be presenting at the
Thomas Weisel Partners Growth Forum on Wednesday, June 18, 2003 at 11:40 a.m.
Pacific Daylight Time (2:40 p.m. EDT). The conference is being held in Santa
Barbara, California.
The presentation will be broadcast live over the Internet, then archived
and available for 10 days following the event. The web cast will be
accessible through the Company's website at http://www.aaipharma.com.
About aaiPharma
aaiPharma Inc. is a leading, science-based specialty pharmaceutical
company with corporate headquarters in Wilmington, North Carolina. With more
than 23 years of drug development expertise and a proven sales and marketing
track record, the Company is focused on acquiring, improving and marketing
well-known, branded medicines in pain management, gastroenterology and
critical care. In addition to its branded product portfolio and robust
pipeline, aaiPharma continues to offer comprehensive drug development services
to the pharmaceutical, biotechnology, generic and device industries through
its services division, AAI International. For more information, please visit
aaiPharma's website at http://www.aaipharma.com.
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
James B. Sloan, Jr., Senior Vice President,
Corporate Finance of aaiPharma Inc., +1-910-254-7690
|
